- Home
- MYFW vs CNTX Comparison
MYFW vs CNTX Comparison
Compare MYFW & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYFW | CNTX |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.6M | 283.9M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MYFW | CNTX |
|---|---|---|
| Price | $24.24 | $3.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $24.25 | $6.00 |
| AVG Volume (30 Days) | 19.8K | ★ 867.2K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.02 | ★ 69.33 |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $96,914,000.00 | N/A |
| Revenue This Year | $20.48 | N/A |
| Revenue Next Year | $9.70 | N/A |
| P/E Ratio | $17.90 | ★ N/A |
| Revenue Growth | ★ 7.60 | N/A |
| 52 Week Low | $17.55 | $0.49 |
| 52 Week High | $28.00 | $3.44 |
Technical Indicators
Market Signals| Indicator | MYFW | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 60.90 |
| Support Level | $22.09 | $2.07 |
| Resistance Level | $26.27 | N/A |
| Average True Range (ATR) | 0.78 | 0.28 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 38.61 | 62.66 |
Price Performance
Historical ComparisonAbout MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.